Common Stock, Shares, Outstanding of PharmaCyte Biotech, Inc. from 30 Apr 2012 to 31 Jul 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PharmaCyte Biotech, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Apr 2012 to 31 Jul 2025.
  • PharmaCyte Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Jul 2025 was 6,795,779, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 6,795,779 -921,499 -12% 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 6,795,779 -1,241,845 -15% 30 Apr 2025 10-Q 18 Dec 2025 2026 Q2
Q4 2024 6,904,894 -1,616,265 -19% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 7,034,259 -1,665,733 -19% 31 Oct 2024 10-Q 13 Dec 2024 2025 Q2
Q2 2024 7,717,278 -1,060,823 -12% 31 Jul 2024 10-Q 17 Sep 2024 2025 Q1
Q1 2024 8,037,624 -8,756,356 -52% 30 Apr 2024 10-K 11 Aug 2025 2025 FY
Q4 2023 8,521,159 -9,687,859 -53% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q3
Q3 2023 8,699,992 -10,826,952 -55% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q2
Q2 2023 8,778,101 -11,971,967 -58% 31 Jul 2023 10-Q 18 Sep 2023 2024 Q1
Q1 2023 16,793,980 -3,927,067 -19% 30 Apr 2023 10-K 13 Aug 2024 2024 FY
Q4 2022 18,209,018 -2,511,186 -12% 31 Jan 2023 10-Q 16 Mar 2023 2023 Q3
Q3 2022 19,526,944 -1,188,860 -5.7% 31 Oct 2022 10-Q 14 Dec 2022 2022 Q2
Q2 2022 20,750,068 +19,138,397 +1187% 31 Jul 2022 10-Q 14 Sep 2022 2023 Q1
Q1 2022 20,721,047 +19,130,963 +1203% 30 Apr 2022 10-K 31 Jul 2023 2023 FY
Q4 2021 20,720,204 -2,320,690,201 -99% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q3
Q3 2021 20,715,804 -2,314,094,601 -99% 31 Oct 2021 10-Q 14 Dec 2021 2022 Q2
Q2 2021 1,611,671 -1,873,532,067 -100% 31 Jul 2021 10-Q 14 Sep 2021 2022 Q1
Q1 2021 1,590,084 +497,659 30 Apr 2021 10-K 28 Jul 2022 2022 FY
Q4 2020 2,341,410,405 +912,939,233 +64% 31 Jan 2021 10-Q 12 Mar 2021 2021 Q3
Q3 2020 2,334,810,405 +1,002,939,233 +75% 31 Oct 2020 10-Q 11 Dec 2020 2021 Q2
Q2 2020 1,875,143,738 +616,972,566 +49% 31 Jul 2020 10-Q 11 Sep 2020 2021 Q1
Q1 2020 1,092,425* -1,184,912,080 30 Apr 2020 10-K 10 Aug 2021 2021 FY
Q4 2019 1,428,471,172 +301,566,667 +27% 31 Jan 2020 10-Q 13 Mar 2020 2020 Q3
Q3 2019 1,331,871,172 +250,421,212 +23% 31 Oct 2019 10-Q 23 Dec 2019 2020 Q2
Q2 2019 1,258,171,172 +178,671,212 +17% 31 Jul 2019 10-Q 13 Sep 2019 2020 Q1
Q1 2019 1,186,004,505 +172,743,861 +17% 30 Apr 2019 10-K 13 Aug 2020 2020 FY
Q4 2018 1,126,904,505 +146,636,694 +15% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q3
Q3 2018 1,081,449,960 +108,282,149 +11% 31 Oct 2018 10-Q 14 Dec 2018 2019 Q2
Q2 2018 1,079,499,960 +106,332,149 +11% 31 Jul 2018 10-Q 12 Sep 2018 2019 Q1
Q1 2018 1,013,260,644 +107,911,597 +12% 30 Apr 2018 10-K 13 Aug 2019 2019 FY
Q4 2017 980,267,811 +108,029,902 +12% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q3
Q3 2017 973,167,811 +124,013,146 +15% 31 Oct 2017 10-Q 14 Dec 2017 2018 Q2
Q2 2017 973,167,811 +124,513,146 +15% 31 Jul 2017 10-Q 13 Sep 2017 2017 Q1
Q1 2017 905,349,047 +124,115,709 +16% 30 Apr 2017 10-K 20 Jul 2018 2018 FY
Q4 2016 872,237,909 +100,874,083 +13% 31 Jan 2017 10-Q 13 Mar 2017 2017 Q3
Q3 2016 849,154,665 +101,710,921 +14% 31 Oct 2016 10-Q 02 Dec 2016 2017 Q2
Q2 2016 848,654,665 +106,043,836 +14% 31 Jul 2016 10-Q 06 Sep 2016 2017 Q1
Q1 2016 781,233,338 +48,472,802 +6.6% 30 Apr 2016 10-K 27 Jul 2017 2017 FY
Q4 2015 771,363,826 +67,906,033 +9.7% 31 Jan 2016 10-Q 08 Mar 2016 2016 Q3
Q3 2015 747,443,744 +51,329,493 +7.4% 31 Oct 2015 10-Q/A 19 Jan 2016 2016 Q2
Q2 2015 742,610,829 +32,254,615 +4.5% 31 Jul 2015 10-Q/A 19 Jan 2016 2016 Q1
Q1 2015 732,760,536 +42,144,822 +6.1% 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q4 2014 703,457,793 +100,499,779 +17% 31 Jan 2015 10-Q 13 Mar 2015 2015 Q3
Q3 2014 696,114,251 +107,702,903 +18% 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 710,356,214 +173,414,866 +32% 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 690,615,714 +208,509,366 +43% 30 Apr 2014 10-K/A 19 Jan 2016 2015 FY
Q4 2013 602,958,014 +145,015,189 +32% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q3
Q3 2013 588,411,348 +143,897,097 +32% 31 Oct 2013 10-Q 16 Dec 2013 2014 Q2
Q2 2013 536,941,348 31 Jul 2013 10-Q 16 Sep 2013 2014 Q1
Q1 2013 482,106,348 +65,813,153 +16% 30 Apr 2013 10-K 04 Aug 2014 2014 FY
Q4 2012 457,942,825 31 Jan 2013 10-Q 26 Mar 2013 2013 Q3
Q3 2012 444,514,251 31 Oct 2012 10-Q 26 Dec 2012 2013 Q2
Q1 2012 416,293,195 30 Apr 2012 10-K 29 Jul 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.